PortfoliosLab logo

Brainstorm Cell Therapeutics Inc. (BCLI)

Equity · Currency in USD · Last updated Nov 29, 2022

Company Info

ISINUS10501E2019
CUSIP10501E201
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.59
Year Range$1.50 - $4.42
EMA (50)$2.82
EMA (200)$3.19
Average Volume$274.54K
Market Capitalization$58.10M

BCLIShare Price Chart


Loading data...

BCLIPerformance

The chart shows the growth of $10,000 invested in Brainstorm Cell Therapeutics Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,077 for a total return of roughly -59.23%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%JulyAugustSeptemberOctoberNovember
-46.46%
-3.35%
BCLI (Brainstorm Cell Therapeutics Inc.)
Benchmark (^GSPC)

BCLICompare to other instruments

Search for stocks, ETFs, and funds to compare with BCLI

BCLIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-53.37%1.61%
6M-46.64%-4.67%
YTD-60.25%-16.83%
1Y-57.49%-13.73%
5Y-16.66%8.59%
10Y-5.16%10.86%

BCLIMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-22.00%-2.24%10.16%-10.71%-2.00%-6.12%-7.25%41.41%22.10%-19.46%-55.34%
202133.48%-32.78%-5.67%-9.40%3.17%6.15%6.05%-13.90%-4.90%-12.27%31.26%5.26%
2020-4.91%71.50%-33.52%32.54%21.14%50.47%20.87%-6.94%34.18%-40.72%-44.92%-18.10%
20193.38%6.54%11.00%-8.29%-8.04%7.92%1.52%-7.23%4.84%-6.92%9.37%7.81%
2018-11.22%-11.78%2.61%4.13%52.44%-22.00%5.90%-4.12%-3.54%-14.79%-4.45%14.15%
201711.81%53.17%-2.30%-2.82%-4.36%5.06%12.29%-8.58%-3.29%3.64%-4.68%-3.69%
2016-13.64%-6.07%15.09%-16.10%-0.89%8.56%5.81%-6.27%0.84%-3.73%-7.33%18.14%
2015-16.18%6.52%4.71%-17.98%4.38%-5.25%-10.80%-5.59%-24.67%21.40%-1.44%4.38%
201441.67%8.82%-0.90%5.45%-5.83%33.28%-12.23%-1.56%-12.88%-11.68%-14.88%54.05%
20133.99%3.49%2.08%-4.90%-9.87%-0.19%14.03%-18.41%-0.77%-3.10%-7.20%3.45%
201212.20%4.35%-8.33%6.82%6.38%10.80%-5.42%-10.69%-3.85%0.00%-13.33%14.36%
201136.84%42.31%-18.92%-5.00%-1.75%75.71%-9.55%-10.11%-21.25%-11.43%-5.02%-22.64%
2010-3.85%32.00%1.52%-19.40%-3.70%-23.08%20.00%-12.50%4.76%-9.09%2.50%-7.32%

BCLISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Brainstorm Cell Therapeutics Inc. Sharpe ratio is -0.70. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50JulyAugustSeptemberOctoberNovember
-0.70
-0.57
BCLI (Brainstorm Cell Therapeutics Inc.)
Benchmark (^GSPC)

BCLIDividend History


Brainstorm Cell Therapeutics Inc. doesn't pay dividends

BCLIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-91.03%
-17.36%
BCLI (Brainstorm Cell Therapeutics Inc.)
Benchmark (^GSPC)

BCLIWorst Drawdowns

The table below shows the maximum drawdowns of the Brainstorm Cell Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Brainstorm Cell Therapeutics Inc. is 91.54%, recorded on Nov 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.54%Oct 9, 2020534Nov 21, 2022
-76.3%Jun 27, 20111145Jan 13, 20161035Feb 25, 20202180
-57.14%Feb 24, 2010209Dec 20, 2010127Jun 23, 2011336
-50.34%Feb 26, 202016Mar 18, 202055Jun 5, 202071
-25.84%Jul 24, 202022Aug 24, 202024Sep 28, 202046
-12.4%Jun 29, 20201Jun 29, 20206Jul 8, 20207
-11.54%Jan 8, 20109Jan 21, 20107Feb 1, 201016
-9.63%Oct 1, 20202Oct 2, 20203Oct 7, 20205
-7.93%Jun 10, 20203Jun 12, 20201Jun 15, 20204
-7.69%Jan 5, 20101Jan 5, 20102Jan 7, 20103

BCLIVolatility Chart

Current Brainstorm Cell Therapeutics Inc. volatility is 174.47%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%350.00%JulyAugustSeptemberOctoberNovember
174.47%
14.31%
BCLI (Brainstorm Cell Therapeutics Inc.)
Benchmark (^GSPC)